Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects

NCT02169583 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Respiratory Tract

Interventions

DRUG: GSK1325756 Solution
DRUG: GSK1325756 Solution Matching Placebo
DRUG: GSK1325756 Tablet
DRUG: GSK1325756 Tablet Matching Placebo

Sponsor

GlaxoSmithKline